Sanofi/BMS, Drug Prices & Medicare Spending

Sanofi/BMS manufactures 3 drugs tracked by Medicare Part D with total spending of $323.0M.

Drugs Tracked

$323.0M

Medicare Spending

$13.29

Avg Cost/Claim

100%

Have Generics

Sanofi/BMS Drugs, Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Clopidogrel	Clopidogrel Bisulfate	$10.00	$145.0M	-28.6%	Yes
2	Plavix	Clopidogrel (brand)	$18.00	$89.0M	-42.4%	Yes
3	Irbesartan	Irbesartan	$18.00	$89.0M	-22.6%	Yes

Frequently Asked Questions

Sanofi/BMS manufactures 3 drugs tracked by Medicare Part D, with total annual spending of $323.0M.

Plavix (Clopidogrel (brand)) is the most expensive at $18.00 per claim.

3 of 3 Sanofi/BMS drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.

For this entity, the underlying data on this page comes from CMS Medicare Part D Drug Spending data. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

Every number on this page links back to CMS Medicare Part D Drug Spending data; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. prescription drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.

Source: CMS Medicare Part D Spending, 2026.